koat.com
New treatments for Crohn's disease being studied - KOAT
New treatment studies and biosimilars could affect future options and access to care. The piece also points out growing pediatric Crohn’s care and supports available (like an infusion center).
People with Crohn’s disease (adults and children), parents/caregivers of children with Crohn’s, clinicians at IBD centers, and patients interested in clinical trials or biosimilars.
What To Know
The KOAT piece reports that the University of New Mexico Hospital is studying new treatments for Crohn’s disease. The story is a local health segment summarizing what Crohn’s is, common symptoms (diarrhea, stomach pain, nausea, fever, weight loss, fatigue, appetite loss), and standard treatments such as steroids and biologic therapies.
It highlights that UNM is participating in studies of new medications and mentions biosimilars as an area of interest, plus research into nutrition and mental health for people with Crohn’s. UNM also notes a rising number of pediatric diagnoses and describes a child-friendly infusion center for delivering biologic therapies.
The article is a general overview rather than a scientific report: it does not provide study names, data, trial phases, or timelines for when new treatments might become available.
If you want details on any specific study, biosimilar, or how nutrition or mental health programs are being tested at UNM, check the hospital’s clinical trials listings or contact their Crohn’s/IBD clinic for up-to-date info.
This is a local news health segment summarizing clinical activity at UNM rather than reporting on specific clinical-trial results. It names research areas (biosimilars, nutrition, mental health) but offers no trial identifiers, outcomes, or timelines. For decisions about treatment, contact your clinician or the study coordinators.
